{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:26:33Z","timestamp":1790479593734,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is an incurable, chronic, disabling disease that primarily affects young adults. Chinese herbal medicine (CHM) is increasingly recognized as a major form of complementary and alternative medicine; however, there is a limited number of systematic analyses regarding its therapeutic effects on MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim of the study<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether CHM, when used alongside conventional treatment, offers additional therapeutic benefits for patients with MS, focusing on clinical efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We searched eight databases from their inception until July 2025 to identify eligible randomized controlled trials (RCTs) involving CHM therapy for MS. Key outcomes assessed included the expanded disability status scale (EDSS), annual relapse rate (ARR), neurological signs scores, clinical symptoms scores, and modified fatigue impact scale (MFIS). The risk of bias was evaluated using the Cochrane Handbook for systematic reviews, while quantitative synthesis was performed with RevMan (version 5.4.1) and Stata (version 18.0) software. This review has been registered at the International Prospective Register of Systematic Reviews database (Registration No. CRD42024605890).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis included 28 RCTs involving a total of 1,971 participants. The combination of CHM and conventional therapy was superior to conventional therapy alone for individuals with MS. This was evidenced by a decrease in the EDSS (mean difference (MD) = \u22120.65; 95% confidence interval (CI): \u22120.96, \u22120.35;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.0001; MD = \u22120.65, ARR (relative risk (RR) = 0.48; 95% CI: 0.31, 0.73;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0007), neurological signs scores (MD = \u22122.96; 95% CI: \u22124.52, \u22121.39;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0002), and MFIS (MD = \u22128.55; 95% CI: \u221210.20, \u22126.89;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.00001). Additionally, there was an improvement in clinical effects (RR = 1.25; 95% CI: 1.19, 1.32;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.00001). No serious adverse effect was reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although the methodological quality of the included RCTs was relatively suboptimal, CHM therapy combined with conventional therapy manifests a promising effectiveness and safety for managing MS. Therefore, well-designed clinical studies are necessary to provide high-quality evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024605890<\/jats:ext-link>\n                      , identifer CRD42024605890.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1635833","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:28:49Z","timestamp":1758518929000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and safety of Chinese herbal medicine for multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaorui","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.phymed.2018.06.017","article-title":"Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: a randomized placebo-controlled clinical trial","volume":"52","author":"Ayoobi","year":"2019","journal-title":"Phytomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12883-016-0595-2","article-title":"Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study","volume":"16","author":"Bertoglio","year":"2016","journal-title":"BMC Neurol."},{"key":"B3","first-page":"387","article-title":"Clinical observation of methylprednisolone combined with Qi Shen Huan Wu capsule in the treatment of relapsing-remitting multiple sclerosis","author":"Bi","year":"2016","journal-title":"Chin. Med. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.13193\/j.issn.1673-7717.2016.09.026","article-title":"Effect of kidney-nourishing, phlegm-resolving and blood-activating method on quality of life of in patients with multiple sclerosis","volume":"9","author":"Chen","year":"2016","journal-title":"Chin. Archives Traditional Chin. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.13457\/j.cnki.jncm.2006.11.016","article-title":"Clinical observation of Guilu Yisui capsules in the treatment of 60 cases of multiple sclerosis","volume":"11","author":"Chen","year":"2006","journal-title":"New J. Traditional Chin. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"577480","DOI":"10.1016\/j.jneuroim.2021.577480","article-title":"Modulation of the HMGB1\/TLR4\/NF-\u03baB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis","volume":"352","author":"Chu","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.16282\/j.cnki.cn11-9336\/r.2014.17.101","article-title":"To observe the effect of methylprednisolone combined with Shenqi Yangsui formula in the treatment of multiple sclerosis","volume":"2","author":"Dong","year":"2014","journal-title":"Cardiovasc. Dis. J. Integr. Traditional Chin. West. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3969\/j.issn.1002-7386.2013.03.086","article-title":"Clinical efficacy of Yiqi Huoxue Huatan decoction on multiple sclerosis","volume":"3","author":"Duan","year":"2013","journal-title":"Hebei Med. J."},{"key":"B9","first-page":"273","article-title":"Treatment of relapsing multiple sclerosis with Erhuang Formula","volume":"29","author":"Fan","year":"2006","journal-title":"J. Beijing Univ. Traditional Chin. Med."},{"key":"B10","first-page":"4220","article-title":"Clinical efficacy observation of Bushen Yisui capsule on relapsing remitting multiple sclerosis with syndrome of deficiency of kidney-liver yin","volume":"9","author":"Fan","year":"2018","journal-title":"Chin. J. Traditional Chin. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.16808\/j.cnki.issn1003-7705.2008.06.008","article-title":"Clinical observation of Dihuang compound (capsule) in the treatment of 38 cases of acute relapsing multiple sclerosis","volume":"6","author":"Gao","year":"2008","journal-title":"Hunan J. Traditional Chin. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.16025\/j.1674-1307.2022.07.001","article-title":"Understanding the pathogenesis and staging treatment of multiple sclerosis","volume":"41","author":"Gao","year":"2022","journal-title":"Beijing J. Traditional Chin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"019","DOI":"10.3969\/j.issn.1674-4985.2024.23.005","article-title":"Observation on the effect of Yisui granules combined with methylprednisolone sodium succinate in the treatment of acute multiple sclerosis","volume":"21","author":"Jie","year":"2024","journal-title":"Med. Innovation China"},{"key":"B15","doi-asserted-by":"publisher","first-page":"102262","DOI":"10.1016\/j.msard.2020.102262","article-title":"Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study","volume":"44","author":"Kol\u010dava","year":"2020","journal-title":"Multiple Scler. Relat. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3969\/j.issn.1003-8914.2012.09.050","article-title":"Clinical observation of Jianpi Bushen Tongluo Detox decoction in the treatment of 28 cases of multiple sclerosis","volume":"9","author":"Li","year":"2012","journal-title":"Guanming J. Chin. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3969\/j.issn.1674-4616.2017.06.003","article-title":"Clinical observation of Tripterygium Wilfordii polyglycosides in the treatment of multiple sclerosis","volume":"9","author":"Li","year":"2017","journal-title":"Res. Integr. Traditional Chin. West. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.3969\/j.issn.1005-9202.2017.19.101","article-title":"Clinical experience of Toufengling in the treatment of multiple sclerosis","volume":"19","author":"Li","year":"2017","journal-title":"Chin. J. Geriatrics"},{"key":"B20","first-page":"22","article-title":"Integrated Chinese and Western medicine in the treatment of 30 cases of multiple sclerosis","volume":"1","author":"Li","year":"2012","journal-title":"Traditional Chin. Med. Res."},{"key":"B21","first-page":"4012","article-title":"Effect of Yishen Busui Tongluo decoction with methylprednisolone on multiple sclerosis and its effect on the expression of inflammatory factors and HMGB1","volume":"28","author":"Li","year":"2019","journal-title":"Mod. J. Integr. Traditional Chin. West. Med."},{"key":"B22","first-page":"1","article-title":"Exploring the clinical effects of Si Miao Pills in the treatment of multiple sclerosis (in remission)","author":"Li","year":"2024","journal-title":"Liaoning J. Traditional Chin. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.3760\/cma.j.cn441417-20241119-14032","article-title":"Clinical effect of Simiao Pill combined with conventional Western medicine in patients with multiple sclerosis","volume":"31","author":"Li","year":"2025","journal-title":"Int. Med. Health Bull."},{"key":"B24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3736\/jcim20120204","article-title":"Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in treatment of multiple sclerosis","volume":"10","author":"Liu","year":"2012","journal-title":"J. Integr. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"981300","DOI":"10.3389\/fphar.2022.981300","article-title":"Demyelinating diseases of the central nervous system registry for patients with traditional Chinese medicine: rationale and design of a prospective, multicenter, observational study","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3760\/cma.j.issn.1673-4246.2015.09.006","article-title":"Clinical evaluation on Yishen-Bushui-Tongluo decoction in the treatment of multiple sclerosis","volume":"37","author":"Lv","year":"2015","journal-title":"Int. J. Traditional Chin. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-021-00519-3","article-title":"The multiple sclerosis prodrome","volume":"17","author":"Makhani","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41582-022-00686-x","article-title":"From the prodromal stage of multiple sclerosis to disease prevention","volume":"10","author":"Marrie","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"101935","DOI":"10.1016\/j.msard.2020.101935","article-title":"No evidence of disease activity: is it an aspirational therapeutic goal in multiple sclerosis?","volume":"40","author":"Mayssam","year":"2020","journal-title":"Multiple Scler. Relat. Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.rec.2021.07.010","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3969\/j.issn.1001-6910.2020.04.07","article-title":"Clinical efficacy of integrated traditional Chinese and Western medicine in the treatment of 30 cases of acute multiple sclerosis","volume":"4","author":"Qian","year":"2020","journal-title":"Traditional Chin. Med. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"B34","first-page":"14","article-title":"Preliminary study on the efficacy of integrated Chinese and Western medicine in preventing and treating relapses of multiple sclerosis","volume":"2","author":"Shi","year":"2004","journal-title":"Guangxi J. Traditional Chin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ctim.2017.02.004","article-title":"Chinese herbal medicine adjunct therapy in patients with acute relapse of multiple sclerosis: a systematic review and meta-analysis","volume":"31","author":"Song","year":"2017","journal-title":"Complementary Ther. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B37","unstructured":"Traditional Chinese medicine could make \u201cHealth for one\u201d true\n          \n          \n          2021"},{"key":"B38","doi-asserted-by":"publisher","first-page":"100010","DOI":"10.1016\/j.lanwpc.2020.100010","article-title":"Incidence of multiple sclerosis in China: a nationwide hospital-based study","volume":"1","author":"Tian","year":"2020","journal-title":"Lancet Regional Health West. Pac."},{"key":"B39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.13799\/j.cnki.mdjyxyxb.2007.02.030","article-title":"Clinical observation of integrated traditional Chinese and Western medicine in the treatment of 32 cases of multiple sclerosis","author":"Wang","year":"2007","journal-title":"J. Mudanjiang Med. Coll."},{"key":"B40","first-page":"82","article-title":"Clinical observation of the effect of Dihuang Yinzi combined with Western medicine in preventing relapses of multiple sclerosis","volume":"9","author":"Wang","year":"2012","journal-title":"J. Sichuan Traditional Chin. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurology"},{"key":"B42","first-page":"1936","article-title":"The expression of ZO-1 mRNA in the central nervous system and the effect of Yishendaluo decoction in experimental autoimmune encephalomyelitis","volume":"21","author":"Wu","year":"2012","journal-title":"J. Emerg. Traditional Chin. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3969\/j.issn.1672-2779.2020.11.034","article-title":"Clinical observation on nourishing liver and kidney recipe in the treatment of multiple sclerosis","volume":"11","author":"Wu","year":"2020","journal-title":"Chin. Med. Mod. Distance Educ. China"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1212\/WNL.0000000000000250","article-title":"Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American academy of neurology","volume":"82","author":"Yadav","year":"2014","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.20235\/j.issn.2095-1752.2025.08.021","article-title":"Clinical effect of Magui Zhuli decoction in the treatment of muliple sclerosis patients with spleen defciency and dampness-heat syndrome","volume":"15","author":"Yuan","year":"2025","journal-title":"Med. Front."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3969\/j.issn.1004-437X.2021.08.051","article-title":"Clinical evaluation of the effect of Yisui granules combined with methylprednisolone in the treatment of multiple sclerosis","volume":"8","author":"Zhang","year":"2021","journal-title":"Henan Med. Res."},{"key":"B47","first-page":"595","article-title":"Clinical research on the treatment of multiple sclerosis with Guishui Tongluo decoction","volume":"6","author":"Zhang","year":"2006","journal-title":"Chin. J. Emerg. Traditional Chin. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"17407","DOI":"10.1038\/srep17407","article-title":"Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1142\/S0192415X20500639","article-title":"PRISMA (preferred reporting items for systematic reviews and meta-analyses) extension for Chinese herbal medicines 2020 (PRISMA-CHM 2020)","volume":"48","author":"Zhang","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"B50","first-page":"55","article-title":"Integrated Chinese and Western medicine treatment of 36 cases of multiple sclerosis","volume":"1","author":"Zhao","year":"2013","journal-title":"China J. Pharm. Econ."},{"key":"B51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3969\/j.issn.1005-1740.2023.04.012","article-title":"The therapeutic effect of tonifying the kidney, detoxifying and dredging collaterals on multiple sclerosis and its influence on the levels of Th17\/Treg cytokines","volume":"4","author":"Zhao","year":"2023","journal-title":"Chin. J. Microcirc."},{"key":"B52","first-page":"704","article-title":"Effects of Yishen Daluo decoction on ERK1\/2 pathway in mice with experimental autoimmune encephalomyelitis","volume":"31","author":"Zhu","year":"2016","journal-title":"China J. Traditional Chin. Med. Pharm."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1635833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:29:11Z","timestamp":1758518951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1635833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":52,"alternative-id":["10.3389\/fphar.2025.1635833"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1635833","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"article-number":"1635833"}}